Okay, let's tackle this question about HCC markers. The question is asking for the marker of hepatocellular carcinoma. First, I need to recall the common tumor markers for HCC. The most well-known one is alpha-fetoprotein (AFP). But I should check if there are others.

Wait, what other markers are there? Maybe carcinoembryonic antigen (CEA) or CA 19-9? No, those are more for other cancers like colorectal. Then there's des-gamma-carboxy prothrombin (DCP), also known as PIVKA-II, which is another marker for HCC. But AFP is the primary one.

So the options might include AFP, CEA, CA 19-9, and maybe others. The correct answer should be AFP. Let me make sure. HCC is associated with elevated AFP levels. DCP is also a marker but not as commonly used as AFP. The question is likely testing knowledge of the main marker.

Now, the core concept here is tumor markers for HCC. The correct answer is AFP. The other options would be other markers for different cancers. Let me structure the explanation accordingly. I need to explain why AFP is correct, why the others are incorrect, and mention the clinical pearl. Also, make sure to note that AFP is elevated in HCC due to fetal liver cell production.

Clinical pearl: Remember that AFP is elevated in HCC and also in germ cell tumors. So when seeing AFP, associate it with HCC and germ cell tumors. That's a key point for exams.

Now, the incorrect options. Let's say the options are A: CEA, B: CA 19-9, C: AFP, D: PSA. Then, C would be correct. The explanation for each wrong option would be that CEA and CA 19-9 are for other cancers, PSA is for prostate cancer.

Need to make sure the explanation is concise but thorough, using proper medical terms. Also, keep the sections as specified. Let me put it all together now.

**Core Concept**
Hepatocellular carcinoma (HCC) is a primary liver malignancy associated with specific tumor markers. Alpha-fetoprotein (AFP) is the most sensitive and specific biomarker for HCC, reflecting fetal liver cell differentiation in malignant hepatocytes.

**Why the Correct Answer is Right**
Alpha-fetoprotein (AFP) is synthesized by fetal liver cells and yolk sac during embryogenesis. In HCC, malignant hepatocytes recapitulate fetal differentiation patterns, leading to elevated serum AFP levels. AFP levels correlate with tumor burden and are used for surveillance in high-risk patients (e.g., cirrhosis). However, AFP may be normal in 30–40% of early HCC cases.

**Why Each Wrong Option is Incorrect**
**Option A:** Carcinoembryonic antigen (CEA) is elevated in gastrointestinal cancers (e.g., colorectal), not HCC.
**Option B:** Prostate-specific antigen (PSA) is specific for prostate cancer, not liver malignancies.
**Option D:** CA 19-9 is a marker for pancreatic and biliary tract cancers, not HCC.

**Clinical Pearl / High-Yield Fact**
Remember: **AFP is the gold

✓ Correct Answer: B. AFP